Ignace H J T de Hingh
Overview
Explore the profile of Ignace H J T de Hingh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
199
Citations
3934
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van de Vlasakker V, Rauwerdink P, Rovers K, Wassenaar E, Creemers G, Los M, et al.
Surg Endosc
. 2024 Sep;
38(11):6566-6576.
PMID: 39285036
Background: The CRC-PIPAC-II study prospectively assessed bidirectional therapy (BT) consisting of first-line palliative systemic therapy and electrostatic precipitation oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (ePIPAC-OX) in patients with unresectable colorectal peritoneal...
12.
van den Heuvel T, Lurvink R, Rovers K, van Hellemond I, de Hingh I
J Surg Oncol
. 2024 Sep;
130(6):1378-1389.
PMID: 39257287
In patients with resectable colorectal peritoneal metastases, it is unclear whether systemic chemotherapy, in addition to cytoreductive surgery-hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), improves overall survival (OS). This systematic review of 12...
13.
van Erning F, van den Heuvel T, Sijtsma F, Boerma D, Brandt-Kerkhof A, Bremers A, et al.
Eur J Surg Oncol
. 2024 Sep;
50(12):108568.
PMID: 39241538
Introduction: To improve care for patients with colorectal peritoneal metastases (CRC-PM) or pseudomyxoma peritonei (PMP), the Dutch CRS-HIPEC quality registry was initiated in 2019. The aims are to describe the...
14.
Guchelaar N, Noordman B, Welten M, van Santen M, de Neijs M, Koolen S, et al.
J Natl Compr Canc Netw
. 2024 Jul;
22(6):405-412.
PMID: 39074509
Background: Palliative systemic treatment is currently standard of care for metastatic gastric cancer. However, patients with peritoneal metastases of gastric origin are often underrepresented in clinical studies due to unmeasurable...
15.
Rauwerdink P, van de Vlasakker V, Wassenaar E, Rovers K, Los M, Herbschleb K, et al.
Eur J Surg Oncol
. 2024 Jun;
50(9):108487.
PMID: 38905732
Background: Palliative systemic therapy alternated with electrostatic precipitation oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (ePIPAC) has never been prospectively investigated in patients with unresectable colorectal peritoneal metastases (CPM). The CRC-PIPAC-II study...
16.
Schouten T, Kroon V, Besselink M, Bosscha K, Busch O, Crobach A, et al.
Ann Surg
. 2024 May;
PMID: 38708885
Objective: To investigate the association between perineural invasion (PNI) and overall survival (OS) in a nationwide cohort of patients with resected pancreatic ductal adenocarcinoma (PDAC), stratified for margin negative (R0)...
17.
Dietz M, Hannink G, Said I, van der Zant F, van de Vlasakker V, Brandt-Kerkhof A, et al.
Eur J Surg Oncol
. 2024 Apr;
50(6):108294.
PMID: 38583215
Introduction: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival outcomes for selected patients with colorectal peritoneal metastases (PM), but recurrence rates are high. The aim of this study...
18.
van der Ven R, van den Heuvel T, Rovers K, Nienhuijs S, van Erning F, de Hingh I
Ann Surg Oncol
. 2024 Mar;
31(6):3787-3788.
PMID: 38498087
No abstract available.
19.
van der Ven R, van den Heuvel T, Rovers K, Nienhuijs S, Boerma D, van Grevenstein W, et al.
Ann Surg Oncol
. 2024 Mar;
31(6):3758-3768.
PMID: 38453767
Background: Before 2016, patients with isolated synchronous colorectal peritoneal metastases (PMCRC) diagnosed in expert centers had a higher odds of undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) and better...
20.
de Graaf N, Zwart M, van Hilst J, van den Broek B, Bonsing B, Busch O, et al.
Br J Surg
. 2024 Feb;
111(2).
PMID: 38415878
Background: Although robotic pancreatoduodenectomy has shown promising outcomes in experienced high-volume centres, it is unclear whether implementation on a nationwide scale is safe and beneficial. The aim of this study...